News

Anticipation Grows for Ascentage Pharma's Upcoming Financial Results

Anticipation Grows for Ascentage Pharma's Upcoming Financial Results

Ascentage Pharma's Imminent Financial Report

Ascentage Pharma, known for its dedication to addressing global unmet medical needs, particularly in hematological malignancies, is gearing up for an important occasion. The biopharmaceutical company will announce its full year 2024 financial results and provide a corporate update on March 27, 2025, at 7:00 am EDT / 7:00 pm HKT.

Invitation to Investors and Analysts

The management team at Ascentage Pharma cordially invites analysts and investors to participate in a conference call and audio webcast presentation. This interactive session will feature a question and answer segment, encouraging engagement from the attendees.

Conference Call Details

The English conference call and accompanying webcast are scheduled for March 27, 2025, at 8:00 am EDT / 8:00 pm HKT. Interested participants are encouraged to register in advance to secure their local or toll-free phone numbers and personal PINs.

Chinese Investor Event

In addition to the English session, Ascentage Pharma will host a Chinese (Mandarin) investor event on March 28, 2025, at 9:30 am HKT (9:30 pm EDT on March 27, 2025). This session will also allow for simultaneous participation through a conference call and webcast.

Webcast Replay Availability

For those who cannot attend the live sessions, the webcast replays for both the English and Chinese conference calls will be available on the Ascentage Pharma website. The recordings will remain accessible for 30 days, allowing stakeholders to catch up on the essential updates.

Company Overview

Ascentage Pharma is dedicated to discovering, developing, and commercializing innovative therapies to meet significant medical needs across the globe. Focusing primarily on hematological malignancies, the company has secured its presence on major stock exchanges, being listed on the Main Board of the Stock Exchange of Hong Kong Limited and the Nasdaq Global Market under the ticker symbol 'AAPG.'

Contact Information

For inquiries, stakeholders can reach out to:
Investor Relations
Hogan Wan, Head of IR and Strategy
Email: Hogan.Wan@ascentage.com
Phone: +86 512 85557777

Stephanie Carrington
Email: Stephanie.Carrington@icrhealthcare.com
Phone: (646) 277-1282

Media Relations
Sean Leous
Email: Sean.Leous@icrhealthcare.com
Phone: (646) 866-4012

Frequently Asked Questions

What is the date of Ascentage Pharma’s financial report?

Ascentage Pharma will release its financial results on March 27, 2025.

What time will the conference calls begin?

The English conference call will start at 8:00 am EDT and the Mandarin event at 9:30 am HKT.

How can I participate in the conference calls?

Participants must register in advance to obtain access numbers and PINs for the calls.

Where can I find the webcast replay?

The replay of both conference calls will be available on the Ascentage Pharma website for 30 days.

What are the core areas of Ascentage Pharma's focus?

Ascentage Pharma primarily focuses on developing therapies for hematological malignancies.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Dan Brown Joins Guidewire: Big Moves in P&C Software

Updated Category News Views 13

Turning the Insurance World on Its Head Just when you think the enterprise software scene is getting predictable, along comes a bit of news to shake things up. Guidewire, a name known in the P&C insurance software world, has roped in a veteran—Dan Brown—who's got more than a quarter-century under his belt shaping product strategies. It’s not just another suit...

Continue Reading
Christmas Injury Lawyers Unveils SC Knowledge Center

Updated Category News Views 6

In the world of legal labyrinths, sometimes you just need a guiding light, especially following a car accident. That's where the freshly launched South Carolina Car Accident Law Knowledge Center steps in. It’s no magic wand, but Christmas Injury Lawyers are certainly trying to cut the chaos. This online hub covers more ground than a small library, boasting 40 guides...

Continue Reading
Hot Property Alert: Prime Storage Facility Sale in Texas

Updated Category News Views 17

Investment Gold in Abilene's Storage Sector Diving headfirst into the world of bricks and mortar, the opportunity brewing over in Abilene, Texas, packs a potent punch for anyone keen on beefing up their real estate portfolio with a top-notch asset. We're talking about Spare Feet Self Storage, a slick, Class A self-storage facility, serving the cream of the crop in a...

Continue Reading
ProClad Unveils Innovative Hybrid 2.0 Cookware

Updated Category News Views 12

Revolutionizing Cookware: The Launch of Hybrid 2.0 Today, everyone's buzzing about ProClad's big reveal—the Hybrid 2.0 Pan. Now, before you roll those skeptical eyes, hear me out. This isn’t your average bit of kitchen fluff; it’s a heavyweight contender stepping into the everyday cooking ring. What they've done here is combine the muscle of stainless steel searing...

Continue Reading
China Automotive Systems Hits Milestone with ASPICE 4.0 CL2

Updated Category News Views 13

An Automotive Feat in R&D Now here's a story that should make waves across the automotive sector. China Automotive Systems, Inc. (NASDAQ: CAAS), a titan of power steering development in China, has nailed it by meeting the ASPICE 4.0 Capability Level 2. That's a big one, folks. Verified by a partnership between a European automaker and UL, this achievement is no fluke....

Continue Reading
GL1F Crypto: A Breakthrough in On-Chain AI for Crypto

Updated Category News Views 8

The Dawn of On-Chain Machine Learning In a world where crypto folks often tout decentralization like it’s the holy grail, GenesisL1 is throwing open the doors to a new kind of crypto playground with GL1F Crypto. A decentralized on-chain AI studio? Sounds like sci-fi, but here we are—hands on the precipice of democratized machine learning in your browser. A Lab in...

Continue Reading
Event Industry Power 50 Voting Surge Ahead of Close

Updated Category News Views 11

An Unexpected Wave of Enthusiasm in Event Industry The Event Industry Power 50 is getting some serious action this year. Over 3,500 votes have already rolled in, smashing last year's numbers with days still left on the clock. It seems like folks can't wait to see their favorite event powerhouses crowned at this year's gala, which kicks off October 27 in New York City....

Continue Reading
#L.A. Rising Podcast: From Fires to International Fame

Updated Category News Views 13

From Ashes to Airwaves Gritty stories of survival often cut deeper than any wonky industry analysis or corporate earnings report. When you've been through the wringer and come out the other side, that experience sticks with you—and for Kim S. Marshall, it ignited something personal yet universal with the #L.A. Rising podcast. Emerging from the 2025 L.A. fires, this...

Continue Reading
Metropolitan Dermatology's Strategic Expansion into Barnegat

Updated Category News Views 13

Diving into Barnegat's Dermatology Landscape Metropolitan Dermatology has taken a strategic step by opening a new location right in the heart of Barnegat, New Jersey. Talk about a win-win for the folks in Ocean County. This isn't just another clinic opening up shop; it's about bringing comprehensive medical and surgical dermatologic care straight to the people who need...

Continue Reading
OMLYCLO Shakes Up U.S. Biologic Market as Key Player

Updated Category News Views 14

Ah, the pharmaceutical game is shifting again, and this time Celltrion USA's putting their chips down with OMLYCLO, the shiny new omalizumab biosimilar. Here we see a product that's not just approved but interchangeable with XOLAIR, making it a front-runner in the allergic and inflammatory conditions battleground. If you're a patient or a provider navigating these murky...

Continue Reading

Top 5 Most Recently Viewed Articles

SilverAssist Enhances Senior Care Solutions with Caring.com Buyout

Updated Category News Views 157

SilverAssist Strengthens Its Position in Senior Care Market In a strategic move aimed at revolutionizing the landscape of senior living referrals, SilverAssist has acquired Caring, LLC, which operates Caring.com. This acquisition establishes SilverAssist as a preeminent player in an increasingly competitive senior housing referral network. Known for connecting families...

Continue Reading
Selectis Health Under Legal Scrutiny for Sale Deal

Updated Category News Views 5

Shareholder Rights on the Line Smells like we've got another shareholder scuffle going down in the Big Apple. Monteverde & Associates PC is shining a light on Selectis Health, Inc. (OTCMKTS: GBCS) in the wake of its proposed acquisition by Black Pearl Equities II, LLC. Now, shareholders are in the hot seat: Are they getting a raw deal with that $5.75 per share? The Fine...

Continue Reading
Insights on Centene Corp's Changing Short Interest Trends

Updated Category News Views 99

Understanding Centene Corp's Short Interest Dynamics Centene Corp (NYSE: CNC) has recently experienced a significant change in its short interest, which is now reported to have decreased by 6.98%. According to the latest exchange data, there are currently 12.59 million shares sold short, accounting for 2.93% of the total shares available for trading. Given the current...

Continue Reading
American Assets Trust Prepares for Q3 Earnings Announcement

Updated Category News Views 132

American Assets Trust Announces Upcoming Earnings Release American Assets Trust, Inc. (NYSE:AAT) is gearing up to share its third quarter 2025 earnings. This announcement will be made through a press release set to go live following market close on a Tuesday. Investors are looking forward to insights into the company’s financial performance. Conference Call Information...

Continue Reading
Meritage Homes Reports Strong Q3 2024 Performance Metrics

Updated Category News Views 219

Meritage Homes Achieves Impressive Growth in Third Quarter 2024 Meritage Homes Corporation (NYSE: MTH), a leading homebuilder, disclosed its third quarter performance results, which marked a significant achievement for the company. The data reflects the period ending in September 2024, showing robust growth and positive shifts in business strategy. Notable Operating...

Continue Reading